Coded Growth Innovation Center (DMSI) Action Cours

Dermisonics, Inc. engages in the provision of medical technology services. The company is headquartered in Henderson, Nevada. The company went IPO on 2003-07-11. The Company’s principal activity is to provide drugs delivery system. Its Transdermal systems deliver drugs through the skin into the bloodstream. Medications delivered via skin patches avoid liver metabolism, a necessary feature for drug molecules to metabolize easily, and allows for lower dosing of medications. There are two types of transdermal delivery systems: passive and active. In passive transdermal systems, the drug diffuses through the skin where it can act locally or penetrate the capillaries for systemic effect. Active patches require a physical force to facilitate the movement of drug molecules across the skin. The company is a development stage company.